Omnicell (OMCL)

Nasdaq Health Care Health Care Technology S&P SmallCap 600

$37.34

-0.69 (-1.81%)

Close of Nov 06, 2026 · end-of-day data

Source: Omnicell's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$695.91M	$712.71M	$787.31M	$897.03M	$892.21M	$1.13B	$1.30B	$1.15B	$1.11B	$1.18B
Cost of revenue	$378.82M	$394.08M	$414.98M	$460.12M	$478.92M	$577.37M	$706.96M	$650.27M	$641.24M	$681.40M
Gross profit	$317.08M	$318.64M	$372.33M	$436.91M	$413.29M	$554.65M	$588.99M	$496.84M	$471.00M	$503.44M
Research & development	$57.80M	$66.02M	$64.84M	$68.64M	$70.16M	$75.72M	$104.97M	$97.11M	$90.41M	$88.67M
Selling, general & admin	$237.88M	$241.47M	$263.10M	$289.92M	$307.61M	$389.43M	$486.34M	$434.59M	$380.25M	$409.61M
Operating income	$21.41M	$11.14M	$44.39M	$78.35M	$35.53M	$89.51M	-$2.32M	-$34.87M	$337.00K	$5.16M
Interest expense	$5.30M	$6.30M	$7.50M	$3.60M	—	—	—	—	—	—
Pre-tax income	$12.98M	$4.51M	$35.62M	$73.93M	$29.35M	$66.01M	-$2.45M	-$20.11M	$25.59M	$11.32M
Income tax	$3.22M	-$26.01M	-$2.11M	$12.60M	-$2.85M	-$11.84M	-$8.10M	$263.00K	$13.06M	$9.27M
Net income	$9.76M	$30.52M	$37.73M	$61.34M	$32.19M	$77.85M	$5.65M	-$20.37M	$12.53M	$2.05M
EBITDA	$79.77M	$62.66M	$95.74M	$131.91M	$96.59M	$162.50M	$84.61M	$52.45M	$82.57M	$83.95M
EPS (basic)	$0.27	$0.81	$0.96	$1.48	$0.76	$1.79	$0.13	$-0.45	$0.27	$0.04
EPS (diluted)	$0.26	$0.79	$0.93	$1.43	$0.74	$1.62	$0.12	$-0.45	$0.27	$0.04
Diluted shares	36.86M	38.71M	40.56M	42.94M	43.74M	47.94M	45.89M	45.21M	46.26M	46.36M
Gross margin	45.6%	44.7%	47.3%	48.7%	46.3%	49.0%	45.4%	43.3%	42.3%	42.5%
Operating margin	3.1%	1.6%	5.6%	8.7%	4.0%	7.9%	-0.2%	-3.0%	0.0%	0.4%
Net margin	1.4%	4.3%	4.8%	6.8%	3.6%	6.9%	0.4%	-1.8%	1.1%	0.2%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$54.49M	$32.42M	$67.19M	$127.21M	$485.93M	$349.05M	$330.36M	$467.97M	$369.20M	$196.52M
Receivables	$150.30M	$190.05M	$196.24M	$218.36M	$190.12M	$240.89M	$299.47M	$252.03M	$256.40M	$216.86M
Inventory	$69.30M	$96.14M	$100.87M	$108.01M	$96.30M	$119.92M	$147.55M	$110.10M	$88.66M	$100.91M
Total current assets	$315.41M	$352.27M	$397.13M	$483.24M	$829.41M	$780.70M	$881.81M	$927.57M	$815.49M	$680.07M
Goodwill	$327.72M	$337.75M	$335.89M	$336.54M	$499.31M	$738.90M	$734.27M	$735.81M	$734.73M	$737.95M
Total assets	$935.10M	$1.02B	$1.08B	$1.24B	$1.82B	$2.14B	$2.21B	$2.23B	$2.12B	$1.97B
Total current liabilities	$180.91M	$205.21M	$204.58M	$237.00M	$276.42M	$876.16M	$428.45M	$367.79M	$595.68M	$476.61M
Short-term debt	$8.41M	$15.21M	$0	—	—	—	—	—	—	—
Long-term debt	$245.73M	$194.92M	$135.42M	$50.00M	—	—	—	—	—	—
Total debt	$254.14M	$210.12M	$135.42M	$50.00M	—	—	—	—	—	—
Total liabilities	$503.50M	$462.02M	$401.62M	$395.56M	$857.00M	$995.81M	$1.08B	$1.04B	$877.65M	$742.91M
Shareholders' equity	$458.84M	$554.34M	$679.62M	$845.25M	$967.50M	$1.15B	$1.13B	$1.19B	$1.24B	$1.23B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$49.90M	$24.83M	$103.97M	$145.01M	$185.87M	$231.81M	$77.78M	$181.09M	$187.72M	$127.30M
Capital expenditures	$13.45M	$15.34M	$23.70M	$15.89M	$22.84M	$28.97M	$47.54M	$41.47M	$36.46M	$40.41M
Free cash flow	$36.45M	$9.49M	$80.27M	$129.11M	$163.03M	$202.84M	$30.25M	$139.62M	$151.26M	$86.89M
Investing cash flow	-$341.32M	-$34.99M	-$54.37M	-$61.66M	-$279.87M	-$412.50M	-$58.67M	-$55.02M	-$52.79M	-$60.36M
Financing cash flow	$263.75M	-$9.88M	-$13.60M	-$23.48M	$456.27M	$47.36M	-$20.95M	$23.42M	-$235.58M	-$218.32M
Share buybacks	$0	$0	$0	$0	$53.03M	$0	$52.21M	$0	$0	$77.60M
Stock-based compensation	$19.50M	$21.86M	$28.89M	$34.05M	$44.70M	$53.16M	$68.25M	$55.30M	$39.32M	$44.50M
Depreciation & amortization	$58.36M	$51.51M	$51.35M	$53.56M	$61.07M	$72.99M	$86.93M	$87.32M	$82.23M	$78.80M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$258.85M	$246.15M	$276.79M	$282.42M	$306.88M	$269.67M	$290.56M	$310.63M	$313.98M	$309.88M	$312.21M	$307.85M
Cost of revenue	$153.44M	$153.53M	$162.44M	$160.15M	$165.12M	$158.73M	$162.88M	$176.13M	$183.66M	$169.52M	$159.27M	$170.03M
Gross profit	$105.40M	$92.62M	$114.35M	$122.27M	$141.76M	$110.94M	$127.68M	$134.50M	$130.32M	$140.36M	$152.94M	$137.83M
Research & development	$26.82M	$22.06M	$21.10M	$21.21M	$26.04M	$20.53M	$21.57M	$24.02M	$22.55M	$21.52M	$20.30M	$22.35M
Selling, general & admin	$101.95M	$92.41M	$90.03M	$94.49M	$103.33M	$102.03M	$97.98M	$102.24M	$107.36M	$101.99M	$100.19M	$100.54M
Operating income	-$23.36M	-$21.85M	$3.22M	$6.56M	$12.40M	-$11.62M	$8.12M	$8.24M	$415.00K	$16.85M	$32.45M	$14.93M
Pre-tax income	-$18.52M	-$17.83M	$8.20M	$11.63M	$23.60M	-$9.53M	$10.45M	$9.70M	$699.00K	$16.91M	$33.83M	$15.80M
Income tax	-$4.14M	-$2.15M	$4.46M	$3.00M	$7.76M	-$2.51M	$4.81M	$4.24M	$2.73M	$5.55M	$9.54M	$4.76M
Net income	-$14.38M	-$15.68M	$3.73M	$8.63M	$15.84M	-$7.02M	$5.64M	$5.46M	-$2.03M	$11.36M	$24.29M	$11.04M
EBITDA	-$1.64M	-$594.00K	$24.02M	$26.76M	$32.36M	$8.38M	$27.72M	$27.64M	$20.23M	$35.43M	$51.25M	$33.33M
EPS (basic)	$-0.32	$-0.34	$0.08	$0.19	$0.34	$-0.15	$0.12	$0.12	$-0.05	$0.25	$0.53	$0.24
EPS (diluted)	$-0.32	$-0.34	$0.08	$0.19	$0.34	$-0.15	$0.12	$0.12	$-0.05	$0.25	$0.52	$0.24
Diluted shares	95.00K	45.73M	46.04M	46.43M	308.00K	46.60M	46.99M	45.90M	-295.00K	45.94M	46.30M	46.47M
Gross margin	40.7%	37.6%	41.3%	43.3%	46.2%	41.1%	43.9%	43.3%	41.5%	45.3%	49.0%	44.8%
Operating margin	-9.0%	-8.9%	1.2%	2.3%	4.0%	-4.3%	2.8%	2.7%	0.1%	5.4%	10.4%	4.9%
Net margin	-5.6%	-6.4%	1.3%	3.1%	5.2%	-2.6%	1.9%	1.8%	-0.6%	3.7%	7.8%	3.6%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$467.97M	$512.36M	$556.78M	$570.63M	$369.20M	$386.83M	$399.00M	$180.05M	$196.52M	$239.22M	$292.17M	$314.86M
Receivables	$252.03M	$248.51M	$241.13M	$251.76M	$256.40M	$251.60M	$232.68M	$245.72M	$216.86M	$249.80M	$227.05M	$236.05M
Inventory	$110.10M	$103.47M	$93.26M	$95.06M	$88.66M	$91.14M	$105.78M	$107.43M	$100.91M	$99.20M	$96.72M	$98.28M
Total current assets	$927.57M	$989.92M	$995.67M	$1.01B	$815.49M	$839.67M	$844.78M	$659.62M	$680.07M	$722.30M	$735.39M	$783.98M
Goodwill	$735.81M	$735.36M	$735.35M	$737.17M	$734.73M	$735.96M	$738.49M	$737.87M	$737.95M	$737.29M	$737.20M	$737.12M
Total assets	$2.23B	$2.28B	$2.29B	$2.30B	$2.12B	$2.15B	$2.15B	$1.95B	$1.97B	$2.00B	$2.00B	$2.06B
Total current liabilities	$367.79M	$416.36M	$407.12M	$961.52M	$595.68M	$607.53M	$594.39M	$456.59M	$476.61M	$483.05M	$447.44M	$473.70M
Total liabilities	$1.04B	$1.10B	$1.09B	$1.07B	$877.65M	$894.37M	$881.88M	$727.70M	$742.91M	$747.48M	$707.25M	$739.58M
Shareholders' equity	$1.19B	$1.19B	$1.20B	$1.23B	$1.24B	$1.26B	$1.26B	$1.22B	$1.23B	$1.26B	$1.29B	$1.32B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$38.41M	$49.95M	$58.70M	$22.75M	$56.31M	$25.92M	$42.76M	$28.27M	$30.35M	$54.50M	$68.31M	$33.05M
Capital expenditures	$9.07M	$8.96M	$9.55M	$8.87M	$9.09M	$11.17M	$11.78M	$9.75M	$7.71M	$12.44M	$8.94M	$11.36M
Free cash flow	$29.34M	$41.00M	$49.15M	$13.89M	$47.23M	$14.75M	$30.97M	$18.51M	$22.64M	$42.06M	$59.37M	$21.69M
Investing cash flow	-$12.37M	-$12.34M	-$13.55M	-$13.34M	-$13.57M	-$15.74M	-$15.92M	-$14.28M	-$14.42M	-$15.87M	-$12.53M	-$13.11M
Financing cash flow	$13.13M	$11.93M	-$16.63M	$3.55M	-$234.43M	$4.04M	-$11.47M	-$219.98M	$9.10M	$2.39M	-$23.38M	-$4.93M
Share buybacks	$0	—	—	$0	$0	—	—	$61.95M	$0	—	—	$0
Stock-based compensation	$12.19M	$8.64M	$10.03M	$11.61M	$9.04M	$10.79M	$10.53M	$11.21M	$11.98M	$9.50M	$12.21M	$11.42M
Depreciation & amortization	$21.72M	$21.25M	$20.80M	$20.20M	$19.97M	$20.00M	$19.60M	$19.40M	$19.81M	$18.57M	$18.80M	$18.40M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.